博瑞生物医药(苏州)股份有限公司-博瑞医药是以研发和创新为驱动的新型生物医药公司，以研发、生产创新药物和高端仿制药为主。
Location: China
Employees: 11-50
Founded date: 2001
Investors 2
| Date | Name | Website |
| - | LAV | lavfund.co... |
| - | SDIC Fund ... | sdicfund.c... |
Mentions in press and media 2
| Date | Title | Description |
| 24.06.2025 | BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Sc... | Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes and overweight, non-obese individuals Preclinical data for BGM1812 su... |
| 08.01.2019 | Daily funding roundup - January 8th, 2019 | LendingFront raised $4M; Headset raised $12.1M; Managed by Q raised $25M; Humatics raised $28M Carson Living: Carson is a real estate tech startup that provides services to unstaffed residential buildings. Carson has raised $3 million in se... |